top of page
A graph on a screen

Real-World Evidence
Research Consulting

Welcome to RWE Research, your partner in medical and payer related real-world evidence generation.

 

From innovative study ideas to impactful publications, we support your research requirements every step of the way.

Medicine
“There has been a trend towards increasing use of RWE in company submissions and acceptance by committees, with NICE committees accepting RWE as primary or supportive evidence...”

National Institute of Health and Care Excellence (NICE)

Business Strategy and Real-World Evidence.

Evidence Generation

Rapid and precise process from idea generation to high impact evidence publication.

Data Analysis and Interpretation

 Show the full potential of your data through advanced analysis for impactful insights.

Insightful Consulting

Tailored consulting partnership with effective internal and external communication to suit your business needs.

t (1)_edited.jpg

ABOUT US

Leaders in
Real-World Evidence.

RWE Research delivers expertise in real world evidence research. We provide innovative scientific solutions for critical business needs.

Latest News 2025

2 JULY 2025

RWE Research Results Reverse Low UACR Restriction for SGLT2i

NICE reversed its prior restriction for dapagliflozin in low UACR CKD, a decision originally based on limited data for a high-risk subgroup (non-T2D, low uACR). This shift demonstrates growing trust in high-quality RWE research to resolve uncertainty where RCT data are limited or lacking.

image.png

NICE

image.png

ESC HF

17 MAY 2025

For the first time describing the cardiorenal disease pathways (HF    CKD or CKD    HF or simultaneous presentation) to comorbid HF+CKD

Cardiorenal Disease Pathways

EHJ

Suspected de novo heart failure

12 FEBRUARY 2025

This RWE research study (REVOLUTION HF) demonstrated the immediate and high risk of heart failure (HF) hospitalization and death in patients presenting in outpatient care with suspected de novo HF. 

bottom of page